FDMT
4D Molecular Therapeutics Inc
NASDAQ: FDMT · HEALTHCARE · BIOTECHNOLOGY
$8.87
+0.68% today
Updated 2026-04-30
Market cap
$479.88M
P/E ratio
—
P/S ratio
5.63x
EPS (TTM)
$-2.42
Dividend yield
—
52W range
$3 – $12
Volume
0.8M
4D Molecular Therapeutics Inc (FDMT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.79M | $14.13M | $6.99M | $13.61M | $18.04M | $3.13M | $20.72M | $37000.00 | $85.21M |
| Revenue growth (YoY) | — | +144.0% | -50.6% | +94.8% | +32.5% | -82.7% | +562.3% | -99.8% | +230194.6% |
| Cost of revenue | $13.57M | $18.36M | $38.72M | $53.04M | $3.02M | $3.88M | $97.10M | $6.71M | $7.63M |
| Gross profit | $-7.78M | $-4.23M | $-31.73M | $-39.43M | $18.04M | $3.13M | $-76.37M | $37000.00 | $77.58M |
| Gross margin | -134.4% | -30.0% | -454.2% | -289.6% | 100.0% | 100.0% | -368.5% | 100.0% | 91.1% |
| R&D | $13.57M | $18.36M | $43.85M | $53.04M | $61.36M | $80.25M | $97.10M | $141.30M | $195.70M |
| SG&A | $3.49M | $6.17M | $13.89M | $17.24M | $28.01M | $32.91M | $36.49M | $46.58M | $49.06M |
| Operating income | $-11.27M | $-10.40M | $-50.76M | $-56.66M | $-71.33M | $-110.03M | $-112.87M | $-187.84M | $-159.55M |
| Operating margin | -194.7% | -73.6% | -726.7% | -416.3% | -395.5% | -3516.5% | -544.6% | -507678.4% | -187.2% |
| EBITDA | $-10.65M | $-9.70M | $-44.62M | $-55.22M | $-68.31M | $-106.15M | $-108.66M | $-181.14M | $-151.92M |
| EBITDA margin | -183.9% | -68.7% | -638.7% | -405.7% | -378.7% | -3392.5% | -524.4% | -489556.8% | -178.3% |
| EBIT | $-11.27M | $-10.40M | $-45.63M | $-56.66M | $-71.33M | $-110.03M | $-112.87M | $-187.84M | $-159.55M |
| Interest expense | $0.00 | $0.00 | $0.00 | $152000.00 | $3.04M | $6.42M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-11.22M | $-9.55M | $-49.31M | $-56.69M | $-68.30M | $-101.08M | $-100.84M | $-160.87M | $-140.11M |
| Net income growth (YoY) | — | +14.9% | -416.2% | -15.0% | -20.5% | -48.0% | +0.2% | -59.5% | +12.9% |
| Profit margin | -193.8% | -67.6% | -705.8% | -416.5% | -378.6% | -3230.3% | -486.6% | -434778.4% | -164.4% |